MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-14-0003744
Dnakor Pharma Private Limited - pharma in Dhanot, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.56 Cr
▼ 78% YoY
Net loss · FY 2025
₹30.82 Lakh
Net margin -19.7%
EBITDA · FY 2025
-₹30.74 Lakh
EBITDA margin -19.7%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹5.5 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
5
As per MCA filings
About Dnakor Pharma Private Limited
Data last updated:
Dnakor Pharma Private Limited is a private limited company based in Dhanot, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2020PTC117356. Its GSTIN is 24AAICD0644G1ZZ (Gujarat).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Rajendrakumar Joitaram Patel and Ankitkumar Dasharathbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 35 Swagat Industrial Esta Nr.Dhanot Ss Vill:Dhanot Tal: Kalol, Gujarat, India – 382715.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.56 Cr, a decline of 78% compared to the previous year. For the same year it recorded a net loss of ₹30.82 Lakh (net margin -19.7%) and EBITDA of -₹30.74 Lakh (EBITDA margin -19.7%).
As per MCA filings, the company has open charges of ₹5.5 Cr on record.
Dnakor Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0003744). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dnakorpharma.com.
Company details
CIN U24100GJ2020PTC117356
Registration Number 117356
Incorporation Date 15 October 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-14-0003744
Key People
Rajendrakumar Joitaram Patel Director Ankitkumar Dasharathbhai Patel Director Babubhai Joitaram Patel Director Recognitions & Rankings of Dnakor Pharma
Contact details
Dnakor Pharma Private Limited's registered office is in Dhanot, Gujarat. Its website is dnakorpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address35 Swagat Industrial Esta Nr.Dhanot Ss Vill:Dhanot Tal: Kalol, Gujarat, India – 382715
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dnakor Pharma Private Limited, buy the company report.
Comprehensive company report
Dnakor Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dnakor Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dnakor Pharma Private Limited, buy the company report.
Financials of Dnakor Pharma Private Limited
FY 2025 filings availableDnakor Pharma Private Limited reported revenue of ₹1.56 Cr (down 78% YoY) for FY 2025.
Revenue · FY 2025
₹1.56 Cr ▼ 78%
Net loss · FY 2025
₹30.82 Lakh margin -19.7%
EBITDA · FY 2025
-₹30.74 Lakh margin -19.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 78%
EBITDA CAGR growth
1 year
▼ 122%
3 years · compounded
▼ 3%
Revenue fell 78% in the latest year. EBITDA fell 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹30.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹30.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -19.7% | ||||
| Net Profit Margin | -19.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dnakor Pharma Private Limited, buy the company report.
Board of directors of Dnakor Pharma Private Limited
Dnakor Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendrakumar Joitaram Patel | Director | 29 May 2021 | 5 Years 4 Months | Current |
| Ankitkumar Dasharathbhai Patel | Director | 29 May 2021 | 5 Years 4 Months | Current |
| Babubhai Joitaram Patel | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
| Anandkumar Dashrathbhai Patel | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
| Dashrathbhai Joitaram Patel Also directs: Vani Lifecare Private Limited | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Dnakor Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Yellowstone Fine Chemicals Private Limited | ₹1.57 Cr (FY 2024) | 78200.0% | Mumbai, Maharashtra, India | |||
| NDH Pharmaceuticals Private Limited | ₹1.57 Cr (FY 2018) | -43.0% | Himachal Pradesh, India | |||
| Vinyltek Plastichem Private Limited | ₹1.57 Cr (FY 2024) | -12.0% | Thane, Maharashtra, India | |||
| Scoobee Agritech (OPC) Private Limited | ₹1.57 Cr (FY 2023) | 14.0% | Hyderabad, Telangana, India | |||
| Samradhi Crop Chemicals Private Limited | ₹1.57 Cr (FY 2022) | 717.0% | Sikandrabad, Uttar Pradesh, India | |||
| Dnakor Pharma Private Limitedthis company | ₹1.56 Cr (FY 2025) | -₹30.82 Lakh | -19.7% | -78.0% | Dhanot, Gujarat, India | |
| Platinum Plaster (India) Limited | ₹1.56 Cr (FY 2016) | Main Nazafgarh Road, Delhi, India | ||||
| Environmental Building Materials India Private Limited | ₹1.56 Cr (FY 2016) | -51.0% | Mumbai, Maharashtra, India | |||
| Healpros Biomedicals Private Limited | ₹1.56 Cr (FY 2024) | -17.0% | Indore, Madhya Pradesh, India | |||
| RPR Lotus Pharmacy Private Limited | ₹1.56 Cr (FY 2022) | 830.0% | Raipur, Chhattisgarh, India | |||
| Jainsons Rotoplast Private Limited | ₹1.56 Cr (FY 2025) | 12.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Dnakor Pharma Private Limited, buy the company report.
Auditor
Dnakor Pharma Private Limited is audited by BHAVIK A. SHAH & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHAVIK A. SHAH & CO. | FY 2024 | 116389 |
Shareholding
The shareholding of Dnakor Pharma Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Dnakor Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2021 | 100517231 | State Bank of India | ₹5.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dnakor Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dnakor Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dnakor Pharma Private Limited has 1 active EPFO establishment as of Mar 25, 2025.
Active EPFO establishments
1
GST
Dnakor Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICD0644G1ZZ | Gujarat | Active | 05 Nov 2020 |
To see the full GST registrations and return filing status of Dnakor Pharma Private Limited, buy the company report.
Recent activity
Dnakor Pharma Private Limited has 7 board changes on record since 2020: 5 appointments and 2 cessations. The latest: Dilipkumar Babubhai Patel ceased to be Director on 27 May 2022.
AGM
Dnakor Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dnakor Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Dilipkumar Babubhai Patel ceased to be Director.
Ceased
Kamleshkumar Manilal Patel ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 5.50 Cr with Charge ID 100517231 was registered on 28 Oct 2021.
Appointed
Ankitkumar Dasharathbhai Patel was appointed as Director.
Appointed
Rajendrakumar Joitaram Patel was appointed as Director.
Appointed
Anandkumar Dashrathbhai Patel was appointed as Director.
Appointed
Babubhai Joitaram Patel was appointed as Director.
Appointed
Dashrathbhai Joitaram Patel was appointed as Director.
Incorporation
15 Oct 2020
Dnakor Pharma Private Limited was registered on 15 Oct 2020 with Roc Ahmedabad & aged 6 years 7 days as per MCA records.
Frequently asked questions
Dnakor Pharma is an active private limited company based in Dhanot, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 October 2020 (6+ years old) and is registered under CIN U24100GJ2020PTC117356.
Dnakor Pharma has 5 current directors:
- Rajendrakumar Joitaram Patel - Director
- Ankitkumar Dasharathbhai Patel - Director
- Babubhai Joitaram Patel - Director
- Anandkumar Dashrathbhai Patel - Director
- Dashrathbhai Joitaram Patel - Director
The latest financial statements of Dnakor Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Dnakor Pharma is 24AAICD0644G1ZZ, registered in Gujarat.
The CIN (Corporate Identification Number) of Dnakor Pharma is U24100GJ2020PTC117356. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dnakor Pharma was incorporated on 15 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Dnakor Pharma by revenue are Yellowstone Fine Chemicals Private Limited, NDH Pharmaceuticals Private Limited, Vinyltek Plastichem Private Limited, Scoobee Agritech (OPC) Private Limited, Samradhi Crop Chemicals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dilipkumar Babubhai Patel ceased to be Director on 27 May 2022. Kamleshkumar Manilal Patel ceased to be Director on 27 May 2022. Ankitkumar Dasharathbhai Patel was appointed as Director on 29 May 2021. Dnakor Pharma has 7 board changes on record in total.
Yes, Dnakor Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-14-0003744).
Dnakor Pharma can be reached through the website dnakorpharma.com. Its registered office is in Dhanot, Gujarat, India.
The registered office of Dnakor Pharma is at 35 Swagat Industrial Esta Nr.Dhanot Ss Vill:Dhanot Tal: Kalol, Gujarat, India – 382715.